Trials / Completed
CompletedNCT03514888
HIPEC After Radical Cystectomy for High Risk Bladder Cancer
A Pilot Study for Hyperthermic Intraperitoneal Chemotherapy After Radical Cystectomy With Pelvic Lymph Node Dissection for High Risk Invasive Bladder Cancer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- Weill Medical College of Cornell University · Academic / Other
- Sex
- All
- Age
- 45 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
This is a non-randomized, non-blinded, pilot study administering hyperthermic intraperitoneal chemotherapy with Mitomycin-C in 10 men and women with muscle-invasive urothelial carcinoma of the bladder undergoing radical cystectomy with pelvic lymph node dissection who have risk factors for tumor recurrence.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | HIPEC | 40mg of Mitomycin-C dissolved in 100ml normal saline will be added into the perfusate and instilled into the patient for a total of 60 minutes. After 60 minutes, the abdomen will be irrigated with 3 liters of normal saline. |
Timeline
- Start date
- 2018-04-19
- Primary completion
- 2021-07-19
- Completion
- 2023-05-23
- First posted
- 2018-05-02
- Last updated
- 2023-08-28
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03514888. Inclusion in this directory is not an endorsement.